Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
抗间皮素抗体药物偶联物anetumab ravtansine联合聚乙二醇化脂质体阿霉素治疗铂耐药卵巢癌的安全性和活性：一项多中心、Ib期剂量递增和扩展研究
期刊:International Journal of Gynecological Cancer
影响因子:4.7
doi:10.1136/ijgc-2022-003927
Santin, Alessandro D; Vergote, Ignace; González-Martín, Antonio; Moore, Kathleen; Oaknin, Ana; Romero, Ignacio; Diab, Sami; Copeland, Larry J; Monk, Bradley J; Coleman, Robert L; Herzog, Thomas J; Siegel, Jonathan; Kasten, Linda; Schlicker, Andreas; Schulz, Anke; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Bulat, Iurie
